-
A MODULAR ONCOLOGY REFERENCE MODEL FOR EARLY ECONOMIC EVALUATION: A CASE STUDY IN EGFR-MUTATED NSCLC
Mar 18, 2026, 21:38 PM -
WHAT'S IN AN ABSTRACT? PICOS REPORTING FREQUENCIES TO INFORM AI-ASSISTED SCREENING
Mar 18, 2026, 21:38 PM -
THE IMPACT OF THE FIRST FAMILY CORONAVIRUS RESPONSE ACT ON HEALTHCARE SERVICE UTILIZATION AMONG MEDICAID BENEFICIARIES WITH SICKLE CELL DISEASE IN WISCONSIN
Mar 18, 2026, 21:38 PM -
TARGET POPULATION SIZE AND LAUNCH PRICE DYNAMICS OF CELL AND GENE THERAPIES (CGTS)
Mar 18, 2026, 21:38 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
SLEEP AND PSYCHOLOGICAL WELL-BEING IN U.S. AND SOUTH KOREAN ADOLESCENTS
Mar 18, 2026, 21:38 PM -
BURDEN OF DISEASE AND PATIENT JOURNEY OF COPD IN BRAZIL: A REAL-WORLD EVIDENCE STUDY USING LINKED PUBLIC DATABASES
Mar 18, 2026, 21:38 PM -
EMBEDDED QUALITATIVE INTERVIEWS - GUIDANCE AND PRACTICE BY MAJOR HTA BODIES
Mar 18, 2026, 21:38 PM -
ASSESSING THE CONCORDANCE BETWEEN SELF-REPORTED NICOTINE PRODUCT USE AND EMR DIAGNOSIS CODES IN THE ALL OF US RESEARCH PROGRAM
Mar 18, 2026, 21:38 PM -
HOSPITALIZATION COSTS ASSOCIATED WITH 30-DAY UNPLANNED READMISSIONS AND POTENTIALLY PREVENTABLE READMISSIONS IN US OLDER PATIENTS WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
Mar 18, 2026, 21:38 PM -
POST-2020 REAL-WORLD EVIDENCE ON PHARMACOTHERAPIES FOR CHRONIC LYMPHOCYTIC LEUKEMIA: A SCOPING REVIEW
Mar 18, 2026, 21:38 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS FOR MENTAL HEALTH DISORDERS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
COMPARING OUTCOME MODELING STRATEGIES FOR ZERO-INFLATED ABSENTEEISM IN REAL-WORLD DATA: IMPLICATIONS FOR INFERENCE ON ANXIETY SEVERITY
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC IMPACT ASSESSMENT OF HORMONAL IUD USE IN REDUCING UNPLANNED PREGNANCIES IN BRAZIL: REAL-WORLD ANALYSIS FROM A BRAZILIAN HEALTH INSURANCE COMPANY
Mar 18, 2026, 21:38 PM -
COST EFFECTIVENESS ANALYSIS OF SONPIRETIGENE ISTEPARVOVEC FOR RETINITIS PIGMENTOSA WITH SEVERE VISION LOSS
Mar 18, 2026, 21:38 PM -
TREATMENT PERSISTENCE OF FIRST-LINE ADVANCED THERAPIES IN OLDER ADULTS WITH ULCERATIVE COLITIS USING US CLAIMS DATA
Mar 18, 2026, 21:38 PM -
PERIOPERATIVE COST-EFFECTIVENESS OF PARTIAL NEPHRECTOMY TECHNIQUES FOR RENAL CELL CARCINOMA IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
DISTRESS THERMOMETER SCORES AND OUTCOMES IN METASTATIC BREAST, COLORECTAL, AND LUNG CANCER: REAL-WORLD EVIDENCE FROM A LARGE US COMMUNITY ONCOLOGY SETTING
Mar 18, 2026, 21:38 PM -
METHODOLOGICAL COMPARISON OF CATEGORIZED VERSUS CONTINUOUS DECLINE IN KIDNEY FUNCTION: INSIGHTS FROM THE CKD CARE MODEL
Mar 18, 2026, 21:38 PM -
UTILITY DATA IN HEALTH TECHNOLOGY ASSESSMENTS IN THE UNITED KINGDOM BY THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
Mar 18, 2026, 21:38 PM
